Yunpeng Liu
Yunpeng Liu
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Not applicable | 2025-01-06 | NCT06480864 | |
| SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer | Advanced Colorectal Cancer; Advanced Gastric Carcinoma; Advanced Gastroesophageal Junction Adenocarcinoma | Not yet recruiting | Phase 2 | 2024-10-30 | NCT06666166 | |
| Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma | Biliary Tract Carcinoma | Not yet recruiting | Not applicable | 2024-06-18 | NCT06463548 |